New and notable treatments, inventions from 2024
If you know anyone with schizophrenia, prediabetes, or low bone density, the FDA is on the ball.
If you know anyone with schizophrenia, prediabetes, or low bone density, the FDA is on the ball.
Symptoms like fatigue and loss of smell and taste are more common among younger patients, according to Northwestern Medicine.
It’s not just psychiatrists. We also need more psychologists, counselors, therapists, and support staff.
How different brain stimulation devices are being tested as an alternative to the standard of care.
For Alzheimer’s, chronic pain, and depression, brain stimulation may help where drugs fail.
A VA leader and senator laid out potential paths forward for psychedelic medicines following the FDA’s rejection of an MDMA treatment for PTSD.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.